Aurinia Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	77.84	5.75	-78.02	-108.18	-180.97	-102.68
Depreciation & Amortization	19.45	19.45	11.65	2.71	2.76	1.37
Loss (Gain) From Sale of Investments	-10.82	-12.73	-12.14	-1.57	0.66	-
Stock-Based Compensation	16.9	31.6	45.31	32.3	31.24	17.45
Other Operating Activities	9.55	-5.12	5.35	2.03	10.24	9.48
Change in Accounts Receivable	5.76	-12.46	-10.61	1.93	-15.42	-0.65
Change in Inventory	-6.08	0.48	-15.87	-9.07	-5.64	-13.93
Change in Accounts Payable	-6.66	0.86	1.24	-0.79	4.08	13.62
Change in Unearned Revenue	9.42	5.79	3.76	3.05	-	-
Change in Other Net Operating Assets	4.77	10.78	15.86	-1.93	-4.65	5.48
Operating Cash Flow	120.1	44.39	-33.46	-79.53	-157.69	-69.86
Capital Expenditures	-0.46	-0.28	-0.72	-0.29	-0.3	-5.67
Sale (Purchase) of Intangibles	0.23	-	-	-	-1.2	-1.68
Investment in Securities	43.45	39.59	5.88	-59.68	-84.53	-150.84
Other Investing Activities	0	-0.04	-11.86	-0.66	-17.84	-
Investing Cash Flow	43.21	39.26	-6.71	-60.63	-103.87	-158.19
Long-Term Debt Repaid	-	-11.99	-10.03	-	-	-
Net Debt Issued (Repaid)	-12.68	-11.99	-10.03	-	-	-
Issuance of Common Stock	15.01	9.27	7.17	3.47	221.11	194.38
Repurchase of Common Stock	-129.6	-46.37	-2.28	-1.04	-	-
Financing Cash Flow	-127.27	-49.09	-5.13	2.43	221.11	194.38
Net Cash Flow	36.05	34.56	-45.3	-137.73	-40.45	-33.67
Free Cash Flow	119.64	44.11	-34.18	-79.82	-158	-75.53
Free Cash Flow Margin	45.01%	18.76%	-19.47%	-59.55%	-346.44%	-150.70%
Free Cash Flow Per Share	0.84	0.30	-0.24	-0.56	-1.22	-0.64
Cash Income Tax Paid	3.82	2.18	0.5	1.98	0.26	0.26
Levered Free Cash Flow	85.21	62.94	-3.89	-35.1	-98.48	-45.77
Unlevered Free Cash Flow	87.98	65.96	-2.16	-35.1	-98.48	-45.77
Change in Working Capital	7.2	5.45	-5.61	-6.82	-21.63	4.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.